Author

M. B. Fessler

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Organism:mouse· 3 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1

Frequent Co-Authors

J. J. Aloor· 2 shared R. M. Tighe· 2 shared A. Birukova· 1 shared A. H. M. Kamal· 1 shared A. Solis· 1 shared A. T. Vose· 1 shared A. V. Misharin· 1 shared C. C. Johnson· 1 shared

Activity by Year

2019-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. J. Aloor

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Tissue-resident alveolar macrophages reduce O3-induced inflammation via MerTK mediated efferocytosis

M. A. Guttenberg, A. T. Vose, A. Birukova, K. Lewars, R. I. Cumming, M. C. Albright, J. I. Mark, C. J. Salazar, S. Swaminathan, Z. Yu, Y. V. Sokolenko, E. Bunyan, M. J. Yaeger, M. B. Fessler, L. G. Que, , R. M. Tighe

This study shows tissue-resident alveolar macrophages reduce O3-induced inflammation by clearing apoptotic cells via MerTK-mediated efferocytosis in mice and humans.

bioRxiv · Nov 6, 2023 · PreprintImmunology

Evaluation of endogenous and therapeutic 25-hydroxycholesterols in murine models of pulmonary SARS-CoV-2 infection

M. B. Fessler, J. Madenspacher, P. J. Baker, K. L. Hilligan, E. Castro, J. Meacham, S.-H. Chen, R. F. Johnson, N. P. Martin, C. J. Tucker, D. Mahapatra, M. Cesta, K. D. Mayer-Barber

This study evaluates the antiviral and inflammatory effects of 25-hydroxycholesterol and its metabolite in murine SARS-CoV-2 models, finding no significant antiviral activity and potential pro-injury effects.

bioRxiv · Sep 12, 2022 · PreprintImmunology

TLR5 participates in the TLR4 receptor complex and biases towards MyD88-dependent signaling in environmental lung injury

S. Hussain, C. C. Johnson, J. Sciurba, X. Meng, V. P. Stober, C. Liu, J. Cypher-Daly, K. Bulek, W. Qian, A. Solis, Y. Sakamachi, C. Trempus, J. J. Aloor, K. Gowdy, W. M. Foster, , S. Garantziotis

This study shows TLR5 associates with TLR4 and biases its signaling toward MyD88 in lung injury responses to LPS, hyaluronan, and O3.

bioRxiv · Oct 3, 2019Immunology

Crosslinking Proteomics Indicates Effects of Simvastatin on the TLR2 interactome and Reveals ACTR1A as a Novel Regulator of the TLR2 Signal Cascade

A. H. M. Kamal, J. J. Aloor, M. B. Fessler, S. Chowdhury

This study uses crosslinking proteomics to show that simvastatin alters the TLR2 interactome and identifies ACTR1A as a new regulator of TLR2 signaling.

bioRxiv · Jan 26, 2019Immunology